-

United Natural Foods, Inc. (UNFI) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against United Natural Foods, Inc.

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired United Natural Foods, Inc. (NYSE: UNFI) securities between March 10, 2021 and March 7, 2023, for violations of the Securities Exchange Act of 1934. United Natural Foods is a distributor of natural, organic, specialty, produce and conventional grocery and non-food products.

What Now: Similarly situated shareholders may be eligible to participate in the class action against United Natural Foods. Shareholders who want to act as lead plaintiff for the class must file their papers by May 19, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: United Natural Foods, Inc. (UNFI) Made False and Misleading Statements Regarding its Business Prospects

According to the complaint, on March 8, 2023, United Natural Foods announced its second quarter 2023 financial results, revealing a $6 million decline in gross profits, despite a 6% increase in net sales. The Company stated that its profits “were challenged as we did not repeat the significant level of procurement gains from rapidly accelerating inflation and inventory gains, due to supply chain volatility, that we experienced in the second quarter of last year.” On this news, the Company’s stock price fell $11.49, or 28.1%, to close at $29.47 per share on March 8, 2023, injuring investors.

During the class period, defendants failed to disclose to investors: (1) that, despite its cost saving Value Path initiative, United Natural Foods had not invested in improving its data management and related infrastructure; (2) that, as a result, the Company could not respond adequately to cost changes, such as inflationary pressure; (3) that, as a result, the Company could not appreciate the benefits of procurement gains and inventory gains achieved during fiscal 2022; and (4) that, as a result of the foregoing, the Company’s profitability would be materially adversely impacted.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against United Natural Foods, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:UNFI

Release Summary
United Natural Foods, Inc. (UNFI) Made False and Misleading Statements Regarding its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder Rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breached fiduciary duties to shareholders. Beta Bionics is a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.On January 8, 2026, Beta Bioni...

Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers and directors violated securities laws and breached fiduciary duties to shareholders. Simulation Plus is a software company serving the pharmaceutical, biotechnology, and chemical industries. On June 11, 2025, Simulations Plus announced preliminary third-quarter fiscal 2025 revenue and updated its full-year fiscal 2025 rev...

Shareholder Notice: Robbins LLP Informs Investors of the Lucid Group, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lucid Group, Inc. (NASDAQ: LCID) securities between February 25, 2026 and April 13, 2026. Lucid is a technology company that designs, develops, manufactures, and sells electric vehicles (“EVs”), EV powertrains, and battery systems.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Alleg...
Back to Newsroom